Browsing by Author Pollicino, Christine

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2005Brain natriuretic peptide: a predictor of cardiovascular outcome in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) studyKirby, Adrienne; Pollicino, Christine; Simes, Robert John; Blankenberg, Stefan; Nestel, P; Tonkin, A; West, M J; White, H D; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreBrain natriuretic peptide: a predictor of cardiovascular outcome in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study, European Heart Journal (English Edition), vol.26, Suppl 1,pp 718-718
2005Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain.Pollicino, Christine; O'Brien, Peter C.; Roos, Daniel E.; Turner, Sandra; School of Public Health: Public HealthCosting the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain., Radiotherapy & Oncology, vol.76,(3),2005,pp 264-269
2005Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.Keech, Anthony (Tony); Kirby, Adrienne; Pollicino, Christine; Simes, Robert John; Baigent, C; Blackwell, L; Buck, G; Cholesterol, T e; Collins, R; Kearney, P M; Peto, R; Sourjina, T; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins., The Lancet, vol.366,(9493),2005,pp 1267-1278
2009Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID studyBarnes, Elizabeth; Keech, Anthony (Tony); Pollicino, Christine; Simes, Robert John; Colquhoun, David M.; Nestel, Paul; Soderberg, S; Tonkin, Andrew; Yallop, Julie; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreLeptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study, International Journal of Obesity, vol.33,(1),2009,pp 123-130
2010Modeling the long-term cost-effectiveness of the caries management system in an Australian populationCurtis, Bradley; Evans, Wendell; Pollicino, Christine; Sbaraini, Alexandra; Schwarz, Eli; Warren, Emma; Dentistry Faculty; Dentistry Faculty; School of Public Health: Public Health; Dentistry Faculty; Dentistry FacultyModeling the long-term cost-effectiveness of the caries management system in an Australian population, Value in Health, vol.13, 6, 2010,pp 750-760
2006Neither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study.Pollicino, Christine; Simes, Robert John; Stocker, Roland; Sullivan, David; Colquhoun, David; Gay, Craig A.; Nestel, Paul; Tonkin, Andrew; Whiting, Malcolm; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; School of Medical Sciences: Pathology; School of Molecular BioscienceNeither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study., Atherosclerosis, vol.187,(1),2006,pp 198-204
2004Randomized Controlled Trial Of The Role Of Positron Emission Tomography In The Management Of Stage I And Ii Non-Small-Cell Lung Cancer.Boyer, Michael; Fulham, Michael; King, Madeleine; McCaughan, Brian; Pollicino, Christine; Viney, Rosalie; Kenny, Patricia M; McLean, Jocelyn M; Central Clinical School: Medicine; Central Clinical School: Medicine; Medicine; Central Clinical School: Surgery; School of Public Health: Public Health; School of Public Health: Public HealthRandomized Controlled Trial Of The Role Of Positron Emission Tomography In The Management Of Stage I And Ii Non-Small-Cell Lung Cancer., Journal of Clinical Oncology, vol.22,(12),2004,pp 2357-2362
2005Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.Kirby, Adrienne; Mehalski, Kirsty; Pollicino, Christine; Simes, Robert John; Baghurst, Katrine; Colquhoun, David; Nestel, Paul; Tonkin, Andrew; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Molecular Bioscience; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials CentreRelation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial., American Journal of Clinical Nutrition, vol.81,(6),2005,pp 1322-1329
2008The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyKirby, Adrienne; Pollicino, Christine; Simes, Robert John; Sullivan, David; Bickel, Christoph; Blankenberg, Stefan; Lubos, Edith; Munzel, Thomas F; Nestel, P; Schnabel, Renate; Tiret, Laurence; Tonkin, Andrew M; West, Malcolm J; White, Harvey D.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: Public Health; School of Public Health: NH&MRC Clinical Trials Centre; Molecular & Microbial BioscienThe value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study, European Heart Journal, vol.29,(8),2008,pp 923-931